Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0345904 (
liver cancer
)
15,188
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Nasopharyngeal carcinoma-associated gene 6 (
NGX6
) is a membrane protein primarily located in the nuclear membrane and cell membrane. Several groups reported that
NGX6
gene was down-regulated in nasopharyngeal carcinoma (NPC), gastric cancer, lung cancer,
liver cancer
, and colorectal cancer and even less in the carcinomas with metastasis. Current studies have demonstrated that
NGX6
possesses various biological functions, such as regulating protein expression of related genes, involving cell signal transduction pathways, negatively controlling cell cycle progression, inhibiting angiogenesis, and increasing the sensitivity of patients to anti-cancer drugs. Some factors regulating the expression level of
NGX6
gene also have been studied. The methylation of promoter of
NGX6
and histone H3K9 negatively regulates its expression, similar to the function of transcription factor special protein-1 (Sp1). However, the regulatory factor early growth response gene 1 (Egr-1) is provided with positive regulation function. This review will summarize the progress of those studies on
NGX6
and elucidate the potential application of
NGX6
for some malignant diseases.
...
PMID:Tumor suppressor NGX6 inhibits the growth and metastasis of multiple cancers. 2688 May 83